Russia expands strategic medicines list to include engineered insulins

Russian PM Mishustin signed an order adding four items, including genetically engineered insulins, to the list of strategically important medicines. This is a routine policy adjustment to secure domestic supply of critical drugs, with no immediate market impact. The move signals continued state intervention in pharmaceutical supply chains amid ongoing sanctions.